CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-κB pathway

Journal of Immunology

Volumn 168, Issue 2, 2002, Pages 744-754

  Zhu, N ^a   Ramirez, L M ^a   Lee, R L ^a   Magnuson, N S ^a   Bishop, G A ^a   Gold, M R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; PHOSPHOTRANSFERASE; PROTEIN; PROTEIN KINASE PIM 1; PROTEIN SERINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

EID: 0037080197     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.2.744     Document Type: Article

References (98)

1. The CD40 antigen and its ligand
2. CD40: A pivotal receptor in the determination of life/death decisions in B lymphocytes
3. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40
4. Antibodies to murine CD40 protect normal and malignant B cells from induced growth arrest
5. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cellspecific antigen Bp50 (CDw40)
6. Engagement of CD40 lowers the threshold for activation of resting B cells via the antigen receptor
7. Properties of mouse CD40: Cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies
8. Germinal centers
9. Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells
10. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death
11. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory
12. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype
13. CD40 figand gene defects responsible for X-linked hyper-IgM syndrome
14. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM
15. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation
16. Humoral immune responses in CD40 ligand-deficient mice
17. CD40CD154 interactions in B-cell signaling
18. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs): Binding site specificity and activation of downstream pathways by distinct TRAFs
19. Cross-linking CD40 on B cells rapidly activates NF-κB
20. Induction of the transcription factors NF-κB, AP-1, and NF-AT during B cell stimulation through the CD40 receptor
21. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells
22. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells
23. Selective activation of c-jun kinase mitogen-activated protein kinase by CD40 on human B cells
24. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases
25. Differential activation of the ERK. JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor
26. Organization and regulation of mitogen-activated protein kinase signaling pathways
27. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2
28. Phosphatidylinositol 3-kinase activation in normal human B lymphocytes: Differential sensitivity of growth and differentiation to wortmannin
29. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α
30. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells
31. A1 expression is stimulated by CD40 in B cells and rescues WEHI-231 cells from anti-IgM-induced death
32. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis
33. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes
34. Maintenance of NF-κB/Rel and c-myc expression during CD40 ligand rescue of WEHI231 early B cells from receptor-mediated apoptosis through modulation of IκB proteins
35. CD40 ligation induces Apo-I/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-I/Fas pathway
36. CD40-mediated lymphotoxth α expression in human B cells is tyrosine kinase dependent
37. CD40 signaling activates CD1 la/ CD18 (LFA-1)-mediated adhesion in B cell
38. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells
39. Induction of B cell costimulatory function by recombinant murine CD40 ligand
40. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40
41. Modulation of E2F activity via signaling through surface IgM and CD40 receptors in WEHI-231 B lymphoma cells
42. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG
43. Recombinant human pim-1 protein exhibits serine/threonine kinase activity
44. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related
45. Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines
46. Stability changes in pim-1 protooncogene mRNA after mitogen stimulation of normal lymphocytes
47. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor
48. Transcriptional induction of pim-1 protein kinase gene expression by interferon γ and posttranscriptional effects on costimutation with steel factor
49. Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells
50. pim-1 protooncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1
51. Interferon-α activates multiple STAT proteins and upregulates proliferation-associated IL-2Rα, c-myc, and pim-1 genes
52. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells
53. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway
54. r 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells
55. Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death
56. Expression of Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/ lpr mice
57. Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors
58. Eμ Nand Eμ L-myc cooperate with Eμ pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice
59. Mice bearing the Eμ-myc and Eμ-pim-1 transgenes develop pre-B-cell leukemia prenatally
60. Monoclonal antibodies to murine CD40 define two distinct functional epitopes
61. Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 proto-oncogene-encoded protein kinase
62. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo
63. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor α-induced mitogen-activated protein kinase and nuclear factor κB signaling pathways
64. Requirement for NF-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes
65. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase
66. Characterization of the proto-oncogene Pim-1: Kinase activity and substrate recognition sequence
67. Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression
68. An α-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression
69. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of IκBα, and protection of WEHI-231 cells from anti-IgM-induced growth arrest
70. Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas
71. Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis
72. Inhibition of NF-κB/ Rel induces apoptosis of murine B cells
73. TGFβ1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: Transcriptional activation of IκBα
74. NF-κB mediated up-regulation of Bcl-x and Bfl-1/Al is required for CD40 survival signaling in B lymphocytes
75. H transcription, and Ig class switching
76. B cells lacking RelB are defective in proliferative responses, but undergo normal maturation to Ig secretion and Ig class switching
77. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli
78. 1 phase restriction point
79. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells
80. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas
81. Growth regulation of the B lymphoma cell line WEHI-231 by anti-Ig, lipopolysaccharide, and other bacterial products
82. Regulation of anti-immunoglobulin-induced B lymphoma growth arrest by transforming growth factor β1 and dexamethasone
83. Toll-like receptors in the induction of the innate immune response
84. Primary structure of the putative human oncogene, pim-1
85. The effect of IL-2 treatment on transcriptional attenuation in protooncogenes pim-1 and c-myb in human thymic blast cells
86. Transcriptional elongation of c-myb is regulated by NF-κB
87. Pim-1 protein expression is regulated by its 5′-untranslated region and translation initiation factor elF-4E
88. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase
89. Pim-1 kinase and p100 cooperate to enhance c-Myb activity
90. Myb proteins in life, death, and differentiation
91. Identification of heterochromatin protein 1 (HPI) as a phosphorylarion target by Pim-1 kinase and the effect of phosphorylarion on transcriptional repression function of HPI
92. PAP-1, a novel target protein of phosphorylation by pim-1
93. Crosslinking of surface IgM activates NF-κB in B lymphocytes
94. Down-modulation of c-Myc expression induces apoptosis of B lymphocyte models of tolerance via clonal deletion
95. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells
96. Cdc25 cell-cycle phosphatase as a target of c-myc
97. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes
98. Reassessing the role of c-Myb in tumorigenesis